We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pharma Cos. Seek To Toss Blood Pressure Drug Antitrust Suit

Law360, New York (March 13, 2017, 8:38 PM EDT) -- Mylan, Teva Pharmaceuticals and other generic-drug manufacturers on Friday slammed antitrust claims brought by drug buyers in New York federal court over an alleged conspiracy to jack up the price of generic blood pressure medication propranolol, arguing that the buyers haven’t plausibly shown there was a price-fixing conspiracy.

The drugmakers said that the direct purchaser plaintiffs’ consolidated amended complaint, even after weeks of fact-finding efforts, still fail to support their claim that the companies developed a price-fixing scheme around propranolol. The new complaint has charts and graphs...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.